Klein-Schwartz Wendy, McGrath Jean
Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
J Am Acad Child Adolesc Psychiatry. 2003 Mar;42(3):288-94. doi: 10.1097/00004583-200303000-00008.
To evaluate trends and toxicity of methylphenidate abuse in pre-teens and adolescents reported to poison centers.
The 1993-1999 American Association of Poison Control Centers Toxic Exposure Surveillance System was queried for methylphenidate abuse cases in children aged 10 through 19 years that were followed to known outcome. Main outcome measures included number of cases annually, toxicity, management site, and coded medical outcome.
Of 759 cases, 42.7% involved 10-through 14-year-olds. For the 530 (70.0%) cases involving methylphenidate only, the frequency increased sevenfold from 1993 to 1999. Of 570 patients (75.1%) managed in a health care facility, 398 were discharged from the emergency department and 172 were admitted. Symptoms occurred more commonly in exposures involving coingestants (84.3%) than in methylphenidate-only exposures (71.1%). The most common symptoms in adolescents with methylphenidate only were tachycardia (31.7%), agitation/irritability (25.7%), and hypertension (11.5%). Outcomes were no effect in 189 cases (24.9%) and mild, moderate, and severe in 318 (41.9%), 245 (32.3%), and 7 (0.9%) patients, respectively.
Poison center data demonstrate increasing frequency of methylphenidate abuse. While the majority of adolescents experienced clinical effects and were managed in a health care facility, outcomes were good, especially in cases involving methylphenidate only.
评估向中毒控制中心报告的12岁以下儿童和青少年中哌甲酯滥用的趋势及毒性。
查询1993 - 1999年美国中毒控制中心协会毒性暴露监测系统,以获取10至19岁儿童中哌甲酯滥用病例,并跟踪至已知结局。主要结局指标包括每年的病例数、毒性、处理地点和编码的医疗结局。
在759例病例中,42.7%涉及10至14岁儿童。在仅涉及哌甲酯的530例(70.0%)病例中,从1993年到1999年,病例数增加了7倍。在570例(75.1%)在医疗机构处理的患者中,398例从急诊科出院,172例住院。合并其他物质摄入的暴露中症状更常见(84.3%),而仅哌甲酯暴露中症状发生率为71.1%。仅使用哌甲酯的青少年中最常见的症状为心动过速(31.7%)、激动/易怒(25.7%)和高血压(11.5%)。结局方面,189例(24.9%)无影响,318例(41.9%)为轻度,245例(32.3%)为中度,7例(0.9%)为重度。
中毒控制中心数据显示哌甲酯滥用频率增加。虽然大多数青少年出现临床症状并在医疗机构处理,但结局良好,尤其是仅涉及哌甲酯的病例。